These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34564679)

  • 1. MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review.
    Niklander S; Guerra D; Contreras F; González-Arriagada W; Marín C
    Med Oral Patol Oral Cir Bucal; 2022 Jan; 27(1):e77-e84. PubMed ID: 34564679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of MicroRNA Signatures Associated with the Progression of Leukoplakia with and without Epithelial Dysplasia.
    Kaunein N; Ramani RS; Koo K; Moore C; Celentano A; McCullough M; Yap T
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of oral leukoplakia: a systematic review of observational studies.
    Warnakulasuriya S; Ariyawardana A
    J Oral Pathol Med; 2016 Mar; 45(3):155-66. PubMed ID: 26189354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
    Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
    Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].
    Nitsche M; Koy S; Mörz M; Koch R; Eckelt U
    Mund Kiefer Gesichtschir; 2007 Dec; 11(6):317-26. PubMed ID: 17990010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia.
    Maimaiti A; Abudoukeremu K; Tie L; Pan Y; Li X
    Gene; 2015 Mar; 558(2):271-7. PubMed ID: 25576219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral premalignant lesions: from a clinical perspective.
    Amagasa T; Yamashiro M; Uzawa N
    Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia.
    Li F; Qiu L; Gao Q; Yu L; Liu H; Xue Z; Tao A
    Genomics; 2023 Sep; 115(5):110686. PubMed ID: 37454941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies.
    Celentano A; Glurich I; Borgnakke WS; Farah CS
    Oral Dis; 2021 May; 27(4):848-880. PubMed ID: 32306449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.
    Villa A; Celentano A; Glurich I; Borgnakke WS; Jensen SB; Peterson DE; Delli K; Ojeda D; Vissink A; Farah CS
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):64-78. PubMed ID: 31140698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside.
    Cai X; Zhang J; Zhang H; Li T
    J Zhejiang Univ Sci B; 2023 May; 24(10):868-882. PubMed ID: 37752089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Gene and MicroRNA Signatures for Oral Cancer Developed from Oral Leukoplakia.
    Zhu G; He Y; Yang S; Chen B; Zhou M; Xu XJ
    Biomed Res Int; 2015; 2015():841956. PubMed ID: 26064958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
    Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
    Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p-EMT.
    Shang Q; Peng J; Jiang Y; Qing M; Zhou Y; Xu H; Chen Q
    Oral Dis; 2023 Nov; 29(8):3232-3242. PubMed ID: 35894087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review.
    Monteiro L; Mello FW; Warnakulasuriya S
    Oral Dis; 2021 Nov; 27(8):1977-1992. PubMed ID: 33290585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.
    Staines K; Rogers H
    Br Dent J; 2017 Dec; 223(9):655-661. PubMed ID: 29097794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
    Li X; Liu L; Zhang J; Ma M; Sun L; Li X; Zhang H; Wang J; Huang Y; Li T
    Sci China Life Sci; 2021 Sep; 64(9):1379-1391. PubMed ID: 34351567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.
    Ramos-García P; González-Moles MÁ; Warnakulasuriya S
    Oral Oncol; 2022 Mar; 126():105734. PubMed ID: 35091134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.